In addition to PARP, oncogene-induced replication stress activates the ATR-CHK1 checkpoint pathway, raising the possibility to exploit the use of CHK1 or ATR inhibition in cancers harboring activated oncogenes (Rundle et al., 2017). The gene discussed is ATR; the disease is cancer.